TRPM8 antagonist

This page covers all TRPM8 antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting TRPM8.

Targets

TRPM8

Phase 3 pipeline (1)

• F# PF-004390 Eye Drops · Johnson & Johnson Consumer Inc. (J&JCI) · Ophthalmology
  PF-004390 is a selective TRPM8 antagonist that blocks cold-sensing ion channels in the eye to reduce ocular pain and discomfort.